【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 15
2 Introduction 16
2.1 Immunochemistry Analyzers Overview 16
3 Products under Development 18
3.1 Immunochemistry Analyzers – Pipeline Products by Stage of Development 18
3.2 Immunochemistry Analyzers – Pipeline Products by Segment 19
3.3 Immunochemistry Analyzers – Pipeline Products by Territory 20
3.4 Immunochemistry Analyzers – Pipeline Products by Regulatory Path 22
3.5 Immunochemistry Analyzers – Pipeline Products by Estimated Approval Date 23
3.6 Immunochemistry Analyzers – Ongoing Clinical Trials 24
4 Immunochemistry Analyzers – Pipeline Products under Development by Companies 25
4.1 Immunochemistry Analyzers Companies – Pipeline Products by Stage of Development 25
4.2 Immunochemistry Analyzers – Pipeline Products by Stage of Development 29
5 Immunochemistry Analyzers Companies and Product Overview 33
5.1 Acreo Swedish ICT AB Company Overview 33
5.1.1 Acreo Swedish ICT AB Pipeline Products & Ongoing Clinical Trials Overview 33
5.2 AESKU.Diagnostics GmbH & Co. KG Company Overview 34
5.2.1 AESKU.Diagnostics GmbH & Co. KG Pipeline Products & Ongoing Clinical Trials Overview 34
5.3 Akonni Biosystems, Inc. Company Overview 36
5.3.1 Akonni Biosystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 36
5.4 Arcxis Biotechnologies Inc. Company Overview 38
5.4.1 Arcxis Biotechnologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 38
5.5 Assay Dynamics, LLC Company Overview 39
5.5.1 Assay Dynamics, LLC Pipeline Products & Ongoing Clinical Trials Overview 39
5.6 Atonomics A/S Company Overview 40
5.6.1 Atonomics A/S Pipeline Products & Ongoing Clinical Trials Overview 40
5.7 Beckman Coulter, Inc. Company Overview 42
5.7.1 Beckman Coulter, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42
5.8 BioMedomics, Inc Company Overview 44
5.8.1 BioMedomics, Inc Pipeline Products & Ongoing Clinical Trials Overview 44
5.9 BioNanovations Corporation Company Overview 47
5.9.1 BioNanovations Corporation Pipeline Products & Ongoing Clinical Trials Overview 47
5.10 BioSIMS Company Overview 48
5.10.1 BioSIMS Pipeline Products & Ongoing Clinical Trials Overview 48
5.11 Boston University Company Overview 49
5.11.1 Boston University Pipeline Products & Ongoing Clinical Trials Overview 49
5.12 Canon U.S.A., Inc. Company Overview 51
5.12.1 Canon U.S.A., Inc. Pipeline Products & Ongoing Clinical Trials Overview 51
5.13 CardioGenics Inc. Company Overview 52
5.13.1 CardioGenics Inc. Pipeline Products & Ongoing Clinical Trials Overview 52
5.14 Celsee Diagnostics, Inc. Company Overview 54
5.14.1 Celsee Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 54
5.15 Cepheid Company Overview 55
5.15.1 Cepheid Pipeline Products & Ongoing Clinical Trials Overview 55
5.16 China Medical Technologies, Inc. Company Overview 58
5.16.1 China Medical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 58
5.17 ChipCare Corp Company Overview 61
5.17.1 ChipCare Corp Pipeline Products & Ongoing Clinical Trials Overview 61
5.18 Clearbridge BioLoc Pte Ltd Company Overview 65
5.18.1 Clearbridge BioLoc Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 65
5.19 Corgenix Medical Corporation Company Overview 66
5.19.1 Corgenix Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 66
5.20 Courtagen Life Sciences, Inc. Company Overview 68
5.20.1 Courtagen Life Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 68
5.21 Curetis N.V. Company Overview 69
5.21.1 Curetis N.V. Pipeline Products & Ongoing Clinical Trials Overview 69
5.22 Denator AB Company Overview 78
5.22.1 Denator AB Pipeline Products & Ongoing Clinical Trials Overview 78
5.23 DiaSorin S.p.A Company Overview 79
5.23.1 DiaSorin S.p.A Pipeline Products & Ongoing Clinical Trials Overview 79
5.24 Dyamed Biotech Pte Ltd Company Overview 81
5.24.1 Dyamed Biotech Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 81
5.25 Dynex Technologies Company Overview 82
5.25.1 Dynex Technologies Pipeline Products & Ongoing Clinical Trials Overview 82
5.26 EKF Diagnostics Holdings Plc Company Overview 83
5.26.1 EKF Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview 83
5.27 Enigma Diagnostics Limited Company Overview 85
5.27.1 Enigma Diagnostics Limited Pipeline Products & Ongoing Clinical Trials Overview 85
5.28 F Cubed LLC Company Overview 86
5.28.1 F Cubed LLC Pipeline Products & Ongoing Clinical Trials Overview 86
5.29 Firalis SAS Company Overview 87
5.29.1 Firalis SAS Pipeline Products & Ongoing Clinical Trials Overview 87
5.30 First Light Biosciences, Inc. Company Overview 89
5.30.1 First Light Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 89
5.31 Florida State University Company Overview 90
5.31.1 Florida State University Pipeline Products & Ongoing Clinical Trials Overview 90
5.32 GenePOC Inc. Company Overview 91
5.32.1 GenePOC Inc. Pipeline Products & Ongoing Clinical Trials Overview 91
5.33 Genera Biosystems Limited Company Overview 93
5.33.1 Genera Biosystems Limited Pipeline Products & Ongoing Clinical Trials Overview 93
5.34 Genevo Biosystems Pte Ltd Company Overview 95
5.34.1 Genevo Biosystems Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 95
5.35 GenMark Diagnostics, Inc. Company Overview 96
5.35.1 GenMark Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 96
5.36 Global Solutions for Infectious Diseases Company Overview 98
5.36.1 Global Solutions for Infectious Diseases Pipeline Products & Ongoing Clinical Trials Overview 98
5.37 GNA Biosolutions GmbH Company Overview 100
5.37.1 GNA Biosolutions GmbH Pipeline Products & Ongoing Clinical Trials Overview 100
5.38 Harvard University Company Overview 102
5.38.1 Harvard University Pipeline Products & Ongoing Clinical Trials Overview 102
5.39 HeatFlow Technologies, Inc. Company Overview 103
5.39.1 HeatFlow Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 103
5.40 Hologic, Inc. Company Overview 104
5.40.1 Hologic, Inc. Pipeline Products & Ongoing Clinical Trials Overview 104
5.41 HTG Molecular Diagnostics, Inc. Company Overview 106
5.41.1 HTG Molecular Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 106
5.42 Immunexpress Pty Ltd Company Overview 108
5.42.1 Immunexpress Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 108
5.43 Immunodiagnostic Systems Holdings plc Company Overview 109
5.43.1 Immunodiagnostic Systems Holdings plc Pipeline Products & Ongoing Clinical Trials Overview 109
5.44 Intelligent Fingerprinting Ltd Company Overview 110
5.44.1 Intelligent Fingerprinting Ltd Pipeline Products & Ongoing Clinical Trials Overview 110
5.45 Johnson & Johnson Company Overview 111
5.45.1 Johnson & Johnson Pipeline Products & Ongoing Clinical Trials Overview 111
5.46 LaserGen, Inc. Company Overview 114
5.46.1 LaserGen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 114
5.47 Lucerna, Inc. Company Overview 115
5.47.1 Lucerna, Inc. Pipeline Products & Ongoing Clinical Trials Overview 115
5.48 Magellan Diagnostics, Inc. Company Overview 116
5.48.1 Magellan Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 116
5.49 Magnisense SAS Company Overview 117
5.49.1 Magnisense SAS Pipeline Products & Ongoing Clinical Trials Overview 117
5.50 MAST GROUP Ltd. Company Overview 118
5.50.1 MAST GROUP Ltd. Pipeline Products & Ongoing Clinical Trials Overview 118
5.51 Maxygen-mobile DNA tests Company Overview 119
5.51.1 Maxygen-mobile DNA tests Pipeline Products & Ongoing Clinical Trials Overview 119
5.52 mBio Diagnostics, Inc. Company Overview 120
5.52.1 mBio Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 120
5.53 McKesson Corporation Company Overview 123
5.53.1 McKesson Corporation Pipeline Products & Ongoing Clinical Trials Overview 123
5.54 MedNostic Technologies, LLC Company Overview 125
5.54.1 MedNostic Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 125
5.55 Mindray Medical International Limited Company Overview 126
5.55.1 Mindray Medical International Limited Pipeline Products & Ongoing Clinical Trials Overview 126
5.56 Mobidiag Ltd. Company Overview 128
5.56.1 Mobidiag Ltd. Pipeline Products & Ongoing Clinical Trials Overview 128
5.57 NanoLab, Inc. Company Overview 130
5.57.1 NanoLab, Inc. Pipeline Products & Ongoing Clinical Trials Overview 130
5.58 Nanosphere, Inc. Company Overview 132
5.58.1 Nanosphere, Inc. Pipeline Products & Ongoing Clinical Trials Overview 132
5.59 Next Dimension Technologies, Inc. Company Overview 134
5.59.1 Next Dimension Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 134
5.60 NorthShore University Health System Company Overview 135
5.60.1 NorthShore University Health System Pipeline Products & Ongoing Clinical Trials Overview 135
5.61 OncoGenesis Company Overview 136
5.61.1 OncoGenesis Pipeline Products & Ongoing Clinical Trials Overview 136
5.62 Optidet Diagnostics Ltd Company Overview 137
5.62.1 Optidet Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 137
5.63 Optofluidics, Inc. Company Overview 138
5.63.1 Optofluidics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 138
5.64 Ostendum R&D BV Company Overview 139
5.64.1 Ostendum R&D BV Pipeline Products & Ongoing Clinical Trials Overview 139
5.65 Polymedco CDP, LLC Company Overview 140
5.65.1 Polymedco CDP, LLC Pipeline Products & Ongoing Clinical Trials Overview 140
5.66 Protomex Life Sciences Company Overview 141
5.66.1 Protomex Life Sciences Pipeline Products & Ongoing Clinical Trials Overview 141
5.67 Qiagen N.V. Company Overview 142
5.67.1 Qiagen N.V. Pipeline Products & Ongoing Clinical Trials Overview 142
5.68 Quanterix Corporation Company Overview 148
5.68.1 Quanterix Corporation Pipeline Products & Ongoing Clinical Trials Overview 148
5.69 QuantuMDx Group Limited Company Overview 149
5.69.1 QuantuMDx Group Limited Pipeline Products & Ongoing Clinical Trials Overview 149
5.70 Quidel Corporation Company Overview 150
5.70.1 Quidel Corporation Pipeline Products & Ongoing Clinical Trials Overview 150
5.71 Radisens Diagnostics Limited Company Overview 152
5.71.1 Radisens Diagnostics Limited Pipeline Products & Ongoing Clinical Trials Overview 152
5.72 Raman Diagnostics Limited Company Overview 154
5.72.1 Raman Diagnostics Limited Pipeline Products & Ongoing Clinical Trials Overview 154
5.73 Rapid Biosensor Systems Company Overview 155
5.73.1 Rapid Biosensor Systems Pipeline Products & Ongoing Clinical Trials Overview 155
5.74 Rapid Diagnostek, Inc. Company Overview 156
5.74.1 Rapid Diagnostek, Inc. Pipeline Products & Ongoing Clinical Trials Overview 156
5.75 Siemens Healthcare Diagnostics Inc. Company Overview 157
5.75.1 Siemens Healthcare Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 157
5.76 Siloam Biosciences, Inc. Company Overview 159
5.76.1 Siloam Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 159
5.77 Singulex, Inc. Company Overview 160
5.77.1 Singulex, Inc. Pipeline Products & Ongoing Clinical Trials Overview 160
5.78 Spire Corporation Company Overview 162
5.78.1 Spire Corporation Pipeline Products & Ongoing Clinical Trials Overview 162
5.79 Stat-Diagnostica & Innovation, S.L. Company Overview 164
5.79.1 Stat-Diagnostica & Innovation, S.L. Pipeline Products & Ongoing Clinical Trials Overview 164
5.80 STRATEC Molecular GmbH Company Overview 165
5.80.1 STRATEC Molecular GmbH Pipeline Products & Ongoing Clinical Trials Overview 165
5.81 Sysmex Corporation Company Overview 167
5.81.1 Sysmex Corporation Pipeline Products & Ongoing Clinical Trials Overview 167
5.82 Tecan Group Ltd Company Overview 169
5.82.1 Tecan Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 169
5.83 Techcomp (Holdings) Limited Company Overview 170
5.83.1 Techcomp (Holdings) Limited Pipeline Products & Ongoing Clinical Trials Overview 170
5.84 The Palo Alto Research Center Company Overview 172
5.84.1 The Palo Alto Research Center Pipeline Products & Ongoing Clinical Trials Overview 172
5.85 TrovaGene, Inc. Company Overview 173
5.85.1 TrovaGene, Inc. Pipeline Products & Ongoing Clinical Trials Overview 173
5.86 Tyncbest Biotechnology Company Overview 175
5.86.1 Tyncbest Biotechnology Pipeline Products & Ongoing Clinical Trials Overview 175
5.87 University of California, Davis Company Overview 177
5.87.1 University of California, Davis Pipeline Products & Ongoing Clinical Trials Overview 177
5.88 University of California, San Diego Company Overview 178
5.88.1 University of California, San Diego Pipeline Products & Ongoing Clinical Trials Overview 178
5.89 University of Michigan Company Overview 180
5.89.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 180
5.90 University of Michigan Pediatric Device Consortium Company Overview 181
5.90.1 University of Michigan Pediatric Device Consortium Pipeline Products & Ongoing Clinical Trials Overview 181
5.91 Wellstat Diagnostics, LLC Company Overview 182
5.91.1 Wellstat Diagnostics, LLC Pipeline Products & Ongoing Clinical Trials Overview 182
5.92 Xanthostat Diagnostics, Inc. Company Overview 184
5.92.1 Xanthostat Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 184
5.93 ZIN Technologies, Inc. Company Overview 185
5.93.1 ZIN Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 185
6 Immunochemistry Analyzers- Recent Developments 186
7 Appendix 262
7.1 Methodology 262
7.2 About GlobalData 264
7.3 Contact Us 265
7.4 Disclaimer 265
【レポート販売概要】
■ タイトル：世界の免疫化学分析装置開発動向：医療機器パイプライン分析2015■ 英文：Immunochemistry Analyzers - Medical Devices Pipeline Assessment, 2015
■ 発行日：2016年1月5日
■ 調査会社：GlobalData
■ 商品コード：GDME0147EPD
■ 調査対象地域：グローバル
- ポリイミドフィルムの世界市場2018-2022About Polyimides Polyimides are synthetic resins that are the polymers of imide monomers. Polyimide films are synthesized by polymerizing an aromatic dianhydride and an aromatic diamine. These films are resistant to extreme temperatures and have good chemical resistance, conductivity, and strength. Technavio’s analysts forecast the Global Polyimide Films market to grow at a CAGR of 9.65% during th …
- ワイヤレスネットワークセキュリティの世界市場2015-2022According to Stratistics MRC, the Global Wireless Network Security Market is valued at $9.56 billion in 2015 and is expected to grow at a CAGR of 13.82% to reach $23.67 billion by 2022. Increasing count of wireless networks in enterprises, rising demand for WLAN security systems, growing adoption of smart phones at work places and encouraging government regulations are some of the key factors fost …
- イソシアネートの世界市場2016-2026Visiongain’s new report assesses that the global isocyanate market will reach $30.31bn in 2016. Are you involved in the isocyanate market or do you intend to be? If so, then you must read this report It’s vital that you keep your knowledge up to date. Market scope: This brand new report from visiongain is a completely fresh market assessment of the isocyanate market based upon the latest informati …
- 医療機器業界のM&A及び投資動向（月別）：May 2013Medical Equipment Monthly Deals Analysis: May 2013 - M&A and Investment Trends Summary GlobalData's “Medical Equipment Monthly Deals Analysis: May 2013 - M&A and Investment Trends” report is an essential source of data and trend analysis on the mergers and acquisitions (M&As) and financings in the medical equipment industry. The report provides detailed information on M&As, equity/debt offerings, …
- 2014 World Animal Health Market Outlook and Leading Supplier Business Strategies and Marketing TacticsThis new 80-page report from Venture Planning Group analyzes business strategies and marketing tactics of the world’s leading animal health companies, including: Five-year forecasts for: - Major market segments - Key geographic regionsAssessment of major U.S. and international trends with potentially significant impact on the animal health industry during the next five years, inclu …
- 油料種子処理の世界市場予測（～2022年）：大豆、菜種、ヒマワリ、綿の種子“Oilseed processing market is projected to grow at a CAGR of 7.37%”The oilseed processing market is valued at USD 210.12 billion in 2015, is projected to grow at a CAGR of 7.37%, to reach USD 344.37 billion by 2022. The market is primarily driven by factors such as high growth in the livestock sector and increase in consumption of edible oil. Latin America is projected to be the fastest-growing re …
- アーモンドミルクの世界市場2016-2020About Almond MilkAlmond milk has emerged as a popular dairy-alternative milk. Over the last few years, the demand for almond milk has increased significantly, especially in North America and Europe. Almond milk has emerged as a good substitute for dairy milk owing to its flavor and blending capability. Almond milk is naturally free from lactose and is also low in calories. Almond milk is also util …
- Ganetespib (Non-Small Cell Lung Cancer)：市場予測と分析（～2022）Ganetespib (Non-Small Cell Lung Cancer) - Forecast and Market Analysis to 2022 Summary Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most common cancer in men and women. Historically, the treatment paradigm has centered around chemotherapy. However, the launch of targeted therapies for patients with specific biomarkers has begun to fragment the NSCLC treatment l …
- 農薬市場：スリナムThis report is a comprehensive research of agrochemicals in Suriname. The first two chapters of the report feature the country profile by giving general information on Suriname and by thoroughly studying its economic state, (including key macroeconomic indicators and their development trends). The third chapter covers common business procedures in the country: from starting a project to closing a …
- 世界の3Dマッピング及び3Dモデリング市場The past decade witnessed a giant leap in various industries, with 3D technology being implemented in various electronic devices and other objects. The need for 3D mapping arose after an attempt to make 2D maps more advanced and look more real. This was done by introducing sensors, cameras, scanners, GPS components, and other acquisition devices to capture the real time 3D images which are created …
- プロピレンの世界市場：ポリプロピレン、酸化プロピレン、アクリロニトリル、アクリル酸、クメンAbout Propylene Propylene is produced through traditional processes like steam cracking and fluid catalytic cracking (FCC). It is obtained as a byproduct of the steam cracking process of natural gas liquids and naphtha that is used for the production ethylene and from gasoline-producing refinery through the FCC process. Propylene and its derivatives are used in industries such as construction, aut …
- 世界のミリ波市場Millimeter Waves are the highest band of radio waves and operate at a frequency range of 20-300 GHz. The radio waves in this band have wavelengths that are in order of millimeters (mm), which is why the waves in this band are called millimeter waves, abbreviated as MM Waves. In wireless communications, frequency is one of the major factors that ascertain the feasibility of the technology. The glob …
- 自動車用安全システムの世界市場：アクティブセーフティー、パッシブセーフティーThe automotive safety systems market is estimated to be USD 93.73 Billion in 2015, and is projected to reach USD 152.59 Billion by 2020, growing at a CAGR of 10.24%. The car safety systems market has witnessed considerable growth in countries such as the U.S., China, India, and Mexico, owing to the increasing vehicle electrification, rising vehicle production, and increasingly stringent safety nor …
- 世界のPTCAバルーンカテーテル市場動向（2012-2016）TechNavio's analysts forecast the Global PTCA Balloon Catheter market to grow at a CAGR of 8.24 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing prevalence of CVD. The Global PTCA Balloon Catheter market has also been witnessing an increase in demand for minimally invasive procedures. However, the availability of alternative procedures …
- Asthma Therapeutics Market to 2019 – Breakthrough Biologics to Enhance Treatment of Severe Asthma and Drive Market GrowthAsthma Therapeutics Market to 2019 - Breakthrough Biologics to Enhance Treatment of Severe Asthma and Drive Market Growth Summary GBI Research, a leading business intelligence provider, has released its latest research report, “Asthma Therapeutics Market to 2019 - Breakthrough Biologics to Enhance Treatment of Severe Asthma and Drive Market Growth”. The asthma market is forecast to grow marginally …
